Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
Morning Overview on MSN
Beer waste makes cultivated meat taste more like the real thing
Scientists are turning a stubborn waste problem from the beer industry into a surprisingly effective tool for making ...
Enrollment of pivotal cohort expected to begin in Q1 2026; ATSN-201 BLA submission on track for early 2028 DURHAM, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene ...
Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...
Cell coverings can be observed in all major groups of organisms, which include animals, plants, fungi, protists and prokaryotes. They play a key role in assuring cell survival or adaptation to certain ...
Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
Continued uncertainty in the market and a lack of profitability continued to weigh heavily on orders. Orders remained well below the 10-year average 28,910 for November. VTNA's Magnus Koeck: November ...
Natural killer (NK) cells are the bodyguards of our immune system. As a first line of defense, they destroy invading pathogens, foreign bodies, and infected cells in early stages, thereby preventing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果